Estrella Immunopharma, Inc. ESLA Q3 2025 earnings

FAQ

When did Estrella Immunopharma, Inc. report Q3 2025 earnings?

Estrella Immunopharma, Inc. (ESLA) reported Q3 2025 earnings on November 12, 2025 before market open.

What were Estrella Immunopharma, Inc.'s Q3 2025 revenue and EPS?

Estrella Immunopharma, Inc. reported eps of $-0.13 for Q3 2025.

Did Estrella Immunopharma, Inc. beat estimates in Q3 2025?

EPS beat the consensus estimate of $-0.19 by $0.06.

How did Estrella Immunopharma, Inc.'s Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps declined 44.4% from $-0.09.

Where can I find Estrella Immunopharma, Inc.'s Q3 2025 SEC filings?

You can read the 10-Q periodic report (0001213900-25-109198) directly on SEC EDGAR. The filing index links above go to sec.gov.